异常甲基丙二酰化导致甲基丙二酸血症,工程化sirtuin可减轻该修饰
研究对甲基丙二酸血症(MMA)患者肝标本及多种甲基丙二酰辅酶A变位酶缺陷小鼠模型进行观察,发现尿素循环和甘氨酸裂解途径的酶存在广泛的甲基丙二酰化修饰;生化研究与小鼠遗传学证实sirtuin 5(SIRT5)调控该修饰;经赖氨酸突变为精氨酸改造的SIRT5装入AAV8载体全身给药后,改善了MMA小鼠的高氨血症并减少整体甲基丙二酰化。
要点
- MMA患者肝标本及小鼠模型显示尿素循环和甘氨酸裂解途径酶存在甲基丙二酰化修饰。
- SIRT5调控MMA相关翻译后修饰的代谢。
- 改造的SIRT5经AAV8递送可改善MMA小鼠高氨血症并减少整体甲基丙二酰化。
核心结论
- 异常甲基丙二酰化修饰抑制尿素循环和甘氨酸裂解途径的酶,是MMA病理生理的机制之一;工程化SIRT5基因治疗可减轻该修饰并改善高氨血症。
研究设计与样本
- 研究检测MMA患者肝标本与未受累供者标本,并平行检测多种甲基丙二酰辅酶A变位酶缺陷小鼠模型的样本。
- 通过生化研究与小鼠遗传学确定SIRT5对MMA相关翻译后修饰的调控作用。
- 将SIRT5经赖氨酸突变为精氨酸以抵抗酰化驱动的抑制,构建AAV8载体并全身递送至突变型和对照小鼠。
主要发现
- MMA中尿素循环和甘氨酸裂解途径的酶存在广泛的甲基丙二酰化修饰。
- 生化研究与小鼠遗传学证实SIRT5控制MMA相关翻译后修饰的代谢。
- AAV8递送改造的SIRT5改善MMA小鼠的高氨血症并减少整体甲基丙二酰化。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Organic acidemias such as methylmalonic acidemia (MMA) are a group of inborn errors of metabolism that typically arise from defects in the catabolism of amino and fatty acids. Accretion of acyl-CoA species is postulated to underlie disease pathophysiology, but the mechanism(s) remain unknown. Here, we surveyed hepatic explants from patients with MMA and unaffected donors, in parallel with samples from various mouse models of methylmalonyl-CoA mutase deficiency. We found a widespread posttranslational modification, methylmalonylation, that inhibited enzymes in the urea cycle and glycine cleavage pathway in MMA. Biochemical studies and mouse genetics established that sirtuin 5 (SIRT5) controlled the metabolism of MMA-related posttranslational modifications. SIRT5 was engineered to resist acylation-driven inhibition via lysine to arginine mutagenesis. The modified SIRT5 was used to create an adeno-associated viral 8 (AAV8) vector and systemically delivered to mutant and control mice. Gene therapy ameliorated hyperammonemia and reduced global methylmalonylation in the MMA mice.
引用
- Head PE, Myung S, Chen Y, et al. Aberrant methylmalonylation underlies methylmalonic acidemia and is attenuated by an engineered sirtuin. Sci Transl Med. 2022. PMID: 35613279. doi:10.1126/scitranslmed.abn4772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。